Atossa Therapeutics, Inc.Atossa Therapeutics, Inc.Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc.

No trades
See on Supercharts

Price target

6.000.000.00%
The 3 analysts offering 1 year price forecasts for ATOS have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to ATOS in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ATOS EPS for the last quarter is −0.06 USD despite the estimation of −0.06 USD. In the next quarter EPS is expected to reach −0.06 USD. Track more of Atossa Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Atossa Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Atossa Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, ATOS price target is 6.00 USD with a max estimate of 7.00 USD and a min estimate of 4.00 USD. Check if this forecast comes true in a year, meanwhile watch Atossa Therapeutics, Inc. stock price chart and keep track of the current situation with ATOS news and stock market news.